Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A).

Fukushima, Takuya; Nomura, Shogo; Shimoyama, Masanori; Shibata, Taro; Imaizumi, Yoshitaka; Moriuchi, Yoshiyuki; Tomoyose, Takeaki; Uozumi, Kimiharu; Kobayashi, Yukio; Fukushima, Noriyasu; Utsunomiya, Atae; Tara, Mitsutoshi; Nosaka, Kisato; Hidaka, Michihiro; Uike, Naokuni; Yoshida, Shinichiro; Tamura, Kazuo; Ishitsuka, Kenji; Kurosawa, Mitsutoshi; Nakata, Masanobu; Fukuda, Haruhiko; Hotta, Tomomitsu; Tobinai, Kensei; Tsukasaki, Kunihiro

doi:10.1111/bjh.12962

Public

Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A).

Shared by NobleBlocks on Sep 1, 2014 • 12:00 AM UTC

Authors:

Takuya Fukushima

Shogo Nomura

Masanori Shimoyama

Abstract

This study evaluated the clinical features of 276 patients with aggressive adult T-cell leukaemia-lymphoma (ATL) in 3 Japan Clinical Oncology Group (JCOG) trials. We assessed the long-term survivors who survived >5 years and constructed a prognostic index (PI), named the JCOG-PI, based on covariates...

Subject

Japan Clinical Oncology Group trials

adult T-cell leukaemia-lymphoma

long-term survivors

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!